Trial site
University Hospital Son Espases
- 162running trials
- 64closed trials
The trials here
What the 229 trials at this site are about, from their registry records.
- Conditions
- Lung cancer40 trials
- Childhood cancers18 trials
- Metastatic breast cancer13 trials
- Multiple myeloma13 trials
- Acute myeloid leukaemia12 trials
- COPD12 trials
- High blood pressure12 trials
- Asthma9 trials
- Pulmonary arterial hypertension9 trials
- HIV8 trials
- Ovarian cancer8 trials
- Endometrial cancer7 trials
- and 55 more
- Phase
- Phase 3141 trials
- Phase 257 trials
- Phase 2/311 trials
- Phase 1/28 trials
- Phase 48 trials
- Phase 13 trials
- Early phase 11 trial
- Status
- Recruiting83 trials
- Completed64 trials
- Active, not recruiting63 trials
- Not yet recruiting16 trials
- Suspended3 trials
- Lead sponsor
- AstraZeneca13 trials
- Fundación GECP9 trials
- Regeneron Pharmaceuticals7 trials
- GlaxoSmithKline6 trials
- Sanofi6 trials
- and 132 more
Running trials
Not yet recruiting
Recruiting
Not yet recruiting
A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
Not yet recruiting
Recruiting
A study on the efficacy of a vaccine against influenza in adults ≥65 years of age
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)
Active, not recruiting
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Showing 50 of 162.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer16 recruiting
- Childhood cancers15 recruiting
- Acute myeloid leukaemia9 recruiting
- COPD6 recruiting
- Ovarian cancer6 recruiting
- Endometrial cancer5 recruiting
- Metastatic breast cancer5 recruiting
- Multiple myeloma4 recruiting
- Prostate cancer4 recruiting
- Acute lymphoblastic leukaemia3 recruiting
- Asthma3 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- High blood pressure3 recruiting
- Bipolar disorder2 recruiting
- Chronic kidney disease2 recruiting
- Colorectal cancer2 recruiting
- Depression2 recruiting
- Diffuse large B-cell lymphoma2 recruiting
- Huntington's disease2 recruiting
- Pulmonary arterial hypertension2 recruiting
- Sarcoma2 recruiting
- Stroke2 recruiting
- Amyloidosis1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Bladder cancer1 recruiting
- Brain metastases1 recruiting
- Bronchiectasis1 recruiting
- Crohn's disease1 recruiting
- Cystic fibrosis1 recruiting
- Cytomegalovirus infection1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Dilated cardiomyopathy1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Hidradenitis suppurativa1 recruiting
- HIV1 recruiting
- Hodgkin lymphoma1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Mesothelioma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroblastoma1 recruiting
- Obesity1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Completed
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Active, not recruiting
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Active, not recruiting
Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Recruiting
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Completed
Completed
A Long-term Follow-up Study of Sotatercept for PAH Treatment
Completed
Completed
DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV:
Completed
Completed
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)
Completed
Completed
Showing 50 of 64.
Site data: ClinicalTrials.govUpdated 18 Nov 2026